Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)
China flag China · Delayed Price · Currency is CNY
33.64
-0.39 (-1.15%)
May 8, 2026, 3:04 PM CST

SHE:002422 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
6,4526,0323,9744,6754,7292,920
Short-Term Investments
-635.45555.65579.39--
Trading Asset Securities
1,8151,4571,9211,691448.11359.53
Cash & Short-Term Investments
8,2688,1246,4516,9465,1773,279
Cash Growth
30.74%25.95%-7.13%34.17%57.88%7.96%
Accounts Receivable
6,2336,0076,0986,1207,1986,463
Other Receivables
122.0282.69126.17162.49256.3221.92
Receivables
6,3566,0906,2246,2837,4546,685
Inventory
3,7933,8473,8013,8403,2143,363
Other Current Assets
2,8691,9781,4601,222804.22681.4
Total Current Assets
21,28520,04017,93618,29016,64914,009
Property, Plant & Equipment
13,09813,07413,01212,08611,33111,614
Long-Term Investments
4,6894,6244,2813,9923,8093,409
Goodwill
96.2596.2598.6698.6698.6698.66
Other Intangible Assets
1,2141,2261,2231,2771,2011,063
Long-Term Deferred Tax Assets
452.69455.25423.03342.57618.21581.57
Long-Term Deferred Charges
92.0690.8783.0675.72233.81365.28
Other Long-Term Assets
214.55228.74260.11293.17264.34400.05
Total Assets
41,14239,83537,31636,45534,20631,540
Accounts Payable
2,5632,5332,5742,5392,2442,156
Accrued Expenses
353.621,9642,2592,0281,9731,610
Short-Term Debt
3,4403,2612,4573,4584,4995,183
Current Portion of Long-Term Debt
656.34151.15808.4746.862,0123,199
Current Portion of Leases
-60.7362.5640.5317.3111.57
Current Income Taxes Payable
233.31125.74140.11162.74108.18119.48
Current Unearned Revenue
490.65563.13645.45839.83360.36264.69
Other Current Liabilities
2,329531.61190.71177.87889.3864.55
Total Current Liabilities
10,0669,1909,1389,99312,10413,408
Long-Term Debt
191.1191.13422,6494,7043,506
Long-Term Leases
528.3544.46537.46245.2351.7416.18
Long-Term Unearned Revenue
316.54326.81294.65288.21208.88225.73
Long-Term Deferred Tax Liabilities
287.63285.2266.09264.1265.83254.32
Other Long-Term Liabilities
5.273.74-0.08--
Total Liabilities
11,39510,54110,57813,43917,33517,410
Common Stock
1,5981,5981,6011,4991,4221,425
Additional Paid-In Capital
8,7958,7687,7326,1443,6733,581
Retained Earnings
14,37713,92413,22211,97310,4169,328
Treasury Stock
-142.07-131.7-191.83-215.14-237.08-399.98
Comprehensive Income & Other
9.7766.39115.84272.07459.82-77.49
Total Common Equity
24,63824,22422,48019,67215,73413,857
Minority Interest
5,1095,0694,2593,3431,137272.62
Shareholders' Equity
29,74729,29426,73823,01616,87114,129
Total Liabilities & Equity
41,14239,83537,31636,45534,20631,540
Total Debt
4,8164,2084,2077,13911,28511,916
Net Cash (Debt)
3,4523,9162,243-193.52-6,108-8,637
Net Cash Growth
100.24%74.58%----
Net Cash Per Share
2.182.461.42-0.13-4.12-6.11
Filing Date Shares Outstanding
1,5641,5901,5911,4881,4121,406
Total Common Shares Outstanding
1,5641,5901,5911,4881,4121,406
Working Capital
11,21910,8508,7988,2974,545600.44
Book Value Per Share
15.7515.2314.1313.2211.159.85
Tangible Book Value
23,32822,90221,15818,29714,43412,695
Tangible Book Value Per Share
14.9114.4013.3012.2910.239.03
Buildings
-7,6657,4646,5576,1606,057
Machinery
-13,79213,10111,59211,34811,078
Construction In Progress
-1,5041,2042,0451,126922.73
Source: S&P Global Market Intelligence. Standard template. Financial Sources.